Paul Sorajja (@psorajja) profile picture

Physician Executive- Lentsch Family Director of Valve & Structural Heart CVSL | Director, Interventional Cardiology | Associate Director, Banner Heart Institute

Phoenix, AZ
Joined March 2022
Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)Photo by Paul Sorajja (@psorajja)
Paul Sorajja retweeted
Congrats to the CVI 2026 Challenging Case Competition Winners! Coronary: BALAKRISHNAN PILLAI, MD Peripheral: ELIZABETH BRUN0, MD Structural: MAHMOUD SALEM, MD See you in Austin, July 29-31, 2027! #cardiotwitter #cardiologyfellow #womenincardiology #interventionalcardiology
1
5
19
1,446
Paul Sorajja retweeted
We are so excited to announce that Dr. Paul Mahoney will be joining our growing team as Director of Transcatheter Valve Therapy. Welcoming you and your expertise, partner! @PaulMahoneyMD Phoenix is Rising. 🐦‍🔥🌵
3
3
27
2,566
Paul Sorajja retweeted
A visionary researcher, dedicated mentor and global leader in cardiovascular medicine, Dr. Amir Lerman’s work reshaped how we understand and treat heart disease. His legacy will endure for generations. 🔗 newsnetwork.mayoclinic.org/d… @MayoClinic
1
12
1
50
4,761
🚨BREAKING NEWS🚨 A historic milestone for AR patients. 🇺🇸 The U.S. Food and Drug Administration has approved the Trilogy® System, the first and only dedicated TAVR therapy for high surgical risk patients with native symptomatic, severe aortic regurgitation in the U.S. For years, symptomatic, severe high-risk AR patients had limited treatment options suited to the challenges or non-calcified anatomy. The Trilogy® System changes that. Introducing a transcatheter therapy designed specifically for native AR anatomy. 👇Learn more about this major clinical advancement: jenavalve.com/trilogy-system… #FDAApproved #TAVR #Cardiology #StructuralHeart #MedTech CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician. IMPORTANT SAFETY INFORMATION: See the link for full indications, contraindications, and cautions: jenavalve.com/#isi
1
31
3
101
16,535
Paul Sorajja retweeted
#WAFIB2026 starting with the masters program! More than 50 fellows/trainees in the room! @westernAFib @DrRoderickTung @PrashSanders @netta_doc @HRSonline
2
27
3,464
Wonderful fellows course to cap off #SIF2026 reviewing patient selection and procedural tips for TAVR and renal denervation! Thank you to our faculty! @PaulSorajj74157 @psorajja @SandeepNathanMD @sudeshnaMD @SIFCardiology @Medtronic
3
7
849
Last day of #SIF2026! ☀️🫀 Don’t miss the final sessions today! 🔗 sif2026.com #CardioTwitter #InterventionalCardiology #CME
1
8
394
Paul Sorajja retweeted
Banner Scottsdale Interventional Forum Live Case Kickoff! ⁦#SIF2026 ⁦@RizikMd⁩ ⁦⁦@psorajja⁩
1
3
18
2,773
Paul Sorajja retweeted
🎉 Happy #NationalWomenPhysiciansDay! Today, we celebrate the women in #InterventionalCardiology whose leadership, innovation, and commitment to patient care continue to move the field forward. #SCAIWIN
7
1
12
2,039
Paul Sorajja retweeted
We know you're busy and times are tight, so we’ve extended Super Early Bird pricing to 2/15! CVI’s 10th Anniversary meeting is August 6-8, 2026 in Denver, CO. Save up to $100. Info and registration at: cvinnovations.org/2026/01/31… #cme #conference #cardiology
1
1
219
#SIF2026 IS NEXT WEEK! 🫀 Get ready for expert-led discussions on today’s most important cardiology topics—don’t miss your chance to be part of it. Register now! sif2026.com #InterventionalCardiology #StructuralHeart #CME @BannerHealth
1
1
6
559
Paul Sorajja retweeted
Super Early Bird pricing ends TONIGHT! - Save up to $100. Register now for CVI's 10th Anniversary! Join us in Denver, 8/6-8/8 for interactive case-based learning. #cme #conference #cardiology Details at: cvinnovations.org/2025/11/30…
1
1
265
Paul Sorajja retweeted
*New first in US transcatheter mitral annular repair* Well done @psorajja and team! #FirstinPHX and many more to come.🔥
1st U.S. case of the Amend ring, a novel percutaneous mitral annuloplasty device. Mimics surgery, reduces MR, and preserves options. Done at BUMC-P with great staff support! Congratulations to entire @BannerHealth team on this milestone for percutaneous MR RX! @DrRoderickTung
1
4
28
6,086